TITLE:
Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

CONDITION:
Bipolar Disorder

INTERVENTION:
Aripiprazole

SUMMARY:

      The purpose of this study is to evaluate flexible doses (5-30mg) of aripiprazole versus
      placebo in patients with bipolar depression.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        -  ages 18-65

          -  Men and women, who have experienced a prior manic episode that required
             hospitalization, and now meet criteria for a major depressive episode.
      
